Workshops: All Senior Programmes

Senior and Top Managers













Level(s): S / U  

Companies need to make profits to survive. They also know they need to have happy customers to survive.  Often, one thing comes at the expense of the other and there is a struggle in the company between those who are working on customer centricity and those who are managing for profits.  There is a way to get both. Your company can achieve profitable customer centricity. The workshop helps senior managers in both finance and commercial functions reconcile the conflict between profits and customer centricity.  The workshop also helps you decide how to implement customer centricity throughout the company – aligning people and using the right metrics to keep people focused on creating loyal, high-value customers that support the long-term financial health of the company.


This workshop features the Net Promoter™ Score1 developed by Bain, Satmetrix and Fred Reichheld.
Profitable Customer Centricity: How Do You Get There ? training info




















Level(s): S / U  

The pharmaceutical industry has reached maturity when it comes to the classical blockbuster model and is fast moving into highly specialized fields like oncology, diabetes and orphan diseases. At the same time, the traditional “size sells” paradigm is no longer working. Medical information and education are key opportunities to succeed in the new healthcare environment and therapeutic areas, ensuring customer engagement, trust and higher revenues.


More than ever before, your customers need medical information and education. Budgets are constantly increasing and skilled resources are hard to obtain. How do you select and manage the right programmes within the tight regulatory framework? How do you assess customer engagement afterwards? What is the role of new channels?


This workshop highlights the new medical interaction and engagement models in-depth.


Medical Affairs and Medical Education: Key to Success training info






Level(s): S / U  
Leadership for Senior Managers: Special Edition for Women training info




































Level(s): S / U  
We all know that we are living in a world that is more global than ever before, thanks to the internet and easy communications. However, most pharmaceutical companies have established regional organisations to coordinate and oversee operations taking place in groups of countries. For a large number of reasons, regional marketing activities may deviate to small or high degree from the global marketing strategies determined by the headquarters. There are good and valid reasons from that, for instance: different portfolios or product life-cycle, different regulatory environment, competitors, medical practices, pricing and distribution channels. For efficiency and productivity reasons, companies try to regionalise their marketing. This represents a fair balance between truly global and purely local marketing but poses number of coordination challenges, which this workshop will review, analyse and propose solutions.
Managing Brands Regionally and Selling Locally: Efficient Marketing Matrix and Processes in Pharma training info


Level(s): S / U  
Patents of blockbuster drugs expire one after another, R&D pipelines are dry, social security deficits explode and push for more healthcare cost containment and generics thrive. Clearly, the growth engine in the Western markets is stalling. Big Pharma is undertaking a dramatic shift in terms of where it can turn to resume growth and secure profitability. As from 2009, it is predicted that “Pharmerging” (or BRIC+TKM) will be responsible for more than 50% of the growth in the global pharmaceutical markets. Except for a few early believers, it is only now that most multinational pharmaceutical companies are waking up and trying to develop and deploy plans to capture a share of the untapped potential in the emerging markets. This workshop will review the alternative strategic options that Big Pharma should consider for the emerging markets and the impacts they will have on your operational model. 
Managing Emerging Markets: Strategic Decisions, Operational Options  training info




Level(s): S / U  
The pharmaceutical industry is undergoing unprecedented transformation. From heavy cost containment from payers, to the infamous “patent cliff”, there are a number of converging forces that drive down value creation in Pharma. Maintaining the ongoing commercial operations, as they have been managed over the last decades, is economically unsustainable. Pharmaceutical companies must adapt to a new environment, which is more demanding than ever before.  They must adopt lower cost models across the whole value chain and improve productivity and efficiency in their commercial approaches. This Commercial Excellence workshop will enable you to reconsider and redesign the way you operate your commercial model, from marketing to medical-marketing and to sales, in order to develop a sustainable competitive advantage for your company. 
“Commercial” Effectiveness in Pharma: Think beyond Sales Force Effectiveness  training info








Level(s): S / U  

Now more than ever, national governments and international institutions such as the EU, the UN and others like OECD, NATO, Eurocontrol, COE, etc., are required to enhance the performance of their Agencies and other Public Bodies which operate under their aegis. Agency CEOs share the same objective and must achieve greater efficiency and value for money in the provision of public services.


Citizens' service delivery expectations have also increased, both as beneficiaries and as taxpayers or funding providers. Those responsible for the executive and non-executive management of Public Organizations and Agencies are therefore under greater pressure to improve organizational performance and achieve ongoing efficiency enhancements.


To date, many governments, cross-border institutions and agency bosses have lacked an integrated or agreed framework for managing the performance of Agencies, Bodies or other third party service providers. More particularly ‘information asymmetries' have meant that it has been difficult to identify performance indicators or the metrics which are necessary to ensure the effective management of such organisations. Obvious questions therefore arise in areas relating to governance, funding, value-for-money and service to citizens.


This new workshop is organized in collaboration with the UCD Michael Smurfit Graduate Business School and RA Consulting. It is a practically based workshop that provides an in-depth understanding of the increasing focus on performance and its criticality within a public service context.  There is a particular emphasis on the development of KPIs and ‘performance contracts' for managing Public Organizations and International Institutions.

Managing Performance in Public Organizations and International Institutions training info


 
Search by keyword
Search by location

Senior and Top Managers training info request
Need more info?
• Leave your phone number here and we'll call you back.
• Send us an email
• Call us: +32 2 543 21 20


   
AmaNet AmaNet Latin America AmaNet Asia CMC Canada MCE Europe, Middle East, Africa